A the latest update from the Go-OUT study molnupiravir showed a relative risk reduction of 30% for hospitalization or Loss of life, plus the relative risk reduction Loss of life was 89%, when molnupiravir when compared with placebo. Similarly, breastfeeding is not encouraged through therapy with molnupiravir and for four https://neoglycyrol33109.collectblogs.com/73638094/article-under-review